ZHX1 and metastatic malignant neoplasm in the lymph nodes: A more recent study indicated that an increased ZHX1 expression was associated with a better or worse prognosis for patients with gastric cancer in the clinical stages, including lymph node metastasis or distant metastasis, and surgical therapy [31].